Linden Advisors’s Bausch Health BHC Stock Holding History

Linden Advisors’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-45,709	Closed	-$505K	–	105
2017 Q1	$505K	Buy	+45,709	New	+$629K	0.02%	105

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Linden Advisors's BHC Position: Q2 2017 in Review

Linden Advisors sold out of Bausch Health (BHC) in Q2 2017, closing a stake of 45,709 shares — an estimated $505K sold.

Linden Advisors first reported a position in BHC in Q1 2017 and held it in 1 quarter. The position peaked at $505K in Q1 2017. 317 funds tracked by Wall St. Rank hold BHC as of Q2 2017.

Linden Advisors reported no remaining Bausch Health position as of Q2 2017 after selling out during the quarter.
Linden Advisors sold 45,709 Bausch Health shares in Q2 2017, an estimated $505K.
Linden Advisors first reported a position in Bausch Health in Q1 2017 and held it in 1 quarter.
Linden Advisors's Bausch Health position peaked at $505K in Q1 2017.
317 funds tracked by Wall St. Rank held Bausch Health as of Q2 2017.

Based on Linden Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.